invivodata Recognized as One of Pittsburgh's Fastest Growing Private Companies

Revenue growth attributed to new products, services, and expanded partner
program

PITTSBURGH, Sept. 1 /PRNewswire/ -- invivodata inc., the industry leader in
electronic patient reported outcomes (ePRO) solutions and services for global
clinical research, today announced that the company has been recognized in the
"2009 Pittsburgh 100" annual ranking of the fastest-growing, privately-held
companies in Western Pennsylvania by the Pittsburgh Business Times.

"We see the Pittsburgh 100 as one of the most important lists we publish,"
said Alan Robertson, publisher of the Pittsburgh Business Times. "The
companies on this list represent many industries and many geographic locations
around the region. The Pittsburgh 100 companies also represent all different
sizes of companies, from small firms to multi-billion dollar operations. The
Pittsburgh 100 is proof that the region remains a vibrant, growth-oriented
business environment."

invivodata was named to the annual Pittsburgh 100 based on its revenue growth
rate from 2006 through 2008. Honored at an awards program at the Duquesne
Club in downtown Pittsburgh on August 27, invivodata was ranked the 16th
fastest-growing technology company and #87 overall on the list of 100, based
on revenue growth.

"We are a proud member of the Pittsburgh business community and are very
pleased to once again be included on this list," said Doug Engfer, invivodata
president and CEO. "We believe our steady growth stems from our commitment to
delivering value with our practical and reliable solutions and services that
help pharmaceutical companies collect better data and run more efficient
clinical trials."

In the past year, invivodata has led the industry in developing innovative
patient and site based ePRO solutions to meet the evolving needs of global
clinical trial sponsors. Strong growth in its scientific and regulatory
consulting division, PRO Consulting(TM), coupled with expanded partnerships
with Contract Research Organizations and integrations with market-leading
eClinical systems has enabled the organization to continue delivering
consistent results to new and existing customers.

For additional information on invivodata's solutions and services, visit
www.invivodata.com.

About invivodata inc.
invivodata combines behavioral science, information technology, and clinical
research expertise to capture high quality clinical trial data directly from
patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions,
which are based on over 20 years of research, deliver reliable patient
self-reported data by driving patient compliance with the protocol and
eliminating recall biases that plague paper-based self-report data.
invivodata's solutions include comprehensive trial-support services that
facilitate the collection of ePRO data, web-based access to study data and
operational reports that give researchers and sponsors visibility into study
progress, and scientific and regulatory consulting on the use of PRO data in a
regulated environment. invivodata's solution has been used in more than 275
clinical programs and is the industry-leading ePRO system in delivering
primary efficacy data for FDA drug approvals. invivodata inc. is a privately
held company with global headquarters in Pittsburgh, Pa., USA; its European
headquarters are in London, England; and its technology development center is
in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.

For more information, contact:

invivodata inc.
Christine Tobin
Corporate Communications Specialist
(412) 390-3000, ext. 3502
ctobin@invivodata.com

SOURCE invivodata inc.

Christine Tobin, Corporate Communications Specialist of invivodata inc.,
+1-412-390-3000, ext. 3502, ctobin@invivodata.com